APA (7th ed.) Citation

Leiter, L. A., Teoh, H., Kallend, D., Wright, R. S., Landmesser, U., Wijngaard, P. L., . . . Ray, K. K. (2019). Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial. Diabetes care, 42(1), 173-176. https://doi.org/10.2337/dc18-1491

Chicago Style (17th ed.) Citation

Leiter, Lawrence A., Hwee Teoh, David Kallend, R. Scott Wright, Ulf Landmesser, Peter L.J Wijngaard, John J.P Kastelein, and Kausik K. Ray. "Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial." Diabetes Care 42, no. 1 (2019): 173-176. https://doi.org/10.2337/dc18-1491.

MLA (9th ed.) Citation

Leiter, Lawrence A., et al. "Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial." Diabetes Care, vol. 42, no. 1, 2019, pp. 173-176, https://doi.org/10.2337/dc18-1491.